An interventional study of compression ultrasound in Deep Vein Thrombosis, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.
Sponsored by University Hospital, Strasbourg, France · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 107 studies in Venous Thrombosis with a site in France — 16 open to participants now, 18 under way, 3 of them phase 3. Venous Thrombosis · France.
Among the 107 studies in Venous Thrombosis with a site in France, this one is the 28th largest by planned enrollment of the 64 interventional ones that give a count, is one of 8 that started in 2022, is one of 19 with no phase, reaches primary completion later than 8 of the 17 other live ones, and was the 82nd registered.
785 studies on the registry are indexed under Venous Thrombosis; 110 are open to participants now.
Browse Venous Thrombosis studies →16 of the 107 studies in Venous Thrombosis with a site in France are open now. Recruiting first, the newest first:
University of Calgary · Sites in France, Belgium, Canada and 4 more countries
Ages 18+ · Women only
Nantes University Hospital · Sites in France
Ages 18+
Centre Hospitalier Universitaire, Amiens · Sites in France
Ages 18+
University Hospital, Brest · Sites in France
Ages 18–80
University Hospital, Brest · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 84 Venous Thrombosis studies recruiting now, 59 (70%) set no upper age limit and 9 (11%) stop at 75 or younger; 10 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
107 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 8 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 700 is above the median of 152 across 477 interventional studies indexed under Venous Thrombosis.
Median enrollment 444 across the 64 interventional studies, 383 across the 43 observational. Of the 83 that completed or were terminated, 18 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
39 of 107 have an industry lead sponsor. The 10 most frequent:
University Hospital, Strasbourg, France is the lead sponsor of 1,000 studies on the registry; 359 are open to participants now.
University Hospital, Strasbourg, France has 2 studies filed under Venous Thrombosis — fewer than ten, so there is no comparison to draw.
5 of the studies in Venous Thrombosis with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04917328University Hospital, Strasbourg, FranceCompression Ultrasonography in Non-high Probability of Deep Vein Thrombosis | 2027-02-28 |
| NCT05711173University Hospital, BordeauxClonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE) | 2027-03 |
| NCT06472518Nantes University HospitalPharmaco Mechanical Thrombolysis Associated With Anticoagulation Compared With Anticoagulation in the Acute Phase of Very Symptomatic Proximal Venous Thrombosis of the Lower Limbs. | 2027-03-01 |
| NCT06385353Centre Hospitalier Intercommunal de Toulon La Seyne sur MerDVT Burden and the Risk of Post-thrombotic Syndrome | 2027-06 |
| NCT07210671Centre Hospitalier Universitaire, AmiensProspective Evaluation of the Treatment of Cancer Associated Superficial Venous | 2027-11 |
Add all 5 to your calendar (.ics) → With an account.
Among the 107 studies in Venous Thrombosis with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Compression ultrasound is commonly used in emergency department. Accuracy to rule out deep vein thrombosis is excellent but lower then Ddimer assessment which is actually gold standard. With progress in formation of emergency physicians (EP), quality of material used, the investigators hypothesize that compression ultrasound can rule out deep vein thrombosis in case of non high probability, as standard care and DDimer assay.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: compression ultrasound
performing a compression ultrasound
Negative predictive value of compression ultrasound for diagnosis of deep vein thrombosis
Time frame: The measurement is assessed during ED stay or in 5 days if DD is positive with no DVT in compression ultrasound
Started Feb 2022 (actual). Primary completion is estimated for Feb 2027, 60 months after the start.
Of 99 non-industry interventional studies with no phase under Venous Thrombosis, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 57. This study's planned 60 months is above that.
Counting every sponsor, half of 117 studies reached it within 34 months; a quarter within 13 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France →